Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Julie E. Bauman, MD, MPH, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00903461
First received: May 14, 2009
Last updated: July 5, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2022
  Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)